Trust Point Inc’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$447K Sell
5,711
-2,438
-30% -$197K 0.04% 247
2026
Q1
$706K Sell
8,149
-534
-6% -$51.2K 0.06% 172
2025
Q4
$834K Sell
8,683
-381
-4% -$37K 0.07% 146
2025
Q3
$863K Sell
9,064
-3,144
-26% -$289K 0.07% 139
2025
Q2
$1.06M Buy
12,208
+3,041
+33% +$258K 0.1% 104
2025
Q1
$824K Sell
9,167
-2,638
-22% -$236K 0.08% 135
2024
Q4
$943K Buy
11,805
+693
+6% +$60K 0.07% 170
2024
Q3
$1M Sell
11,112
-398
-3% -$33.5K 0.08% 165
2024
Q2
$906K Sell
11,510
-358
-3% -$29.3K 0.07% 166
2024
Q1
$1.03M Buy
11,868
+1,313
+12% +$112K 0.08% 154
2023
Q4
$870K Buy
+10,555
New +$804K 0.07% 158

Other funds holding MDT

Trust Point Inc's MDT Position: Q2 2026 in Review

Trust Point Inc reduced its Medtronic (MDT) stake by 30% in Q2 2026, selling an estimated $197K and leaving 5,711 shares worth $447K. The position accounts for 0.04% of the portfolio, ranked #247.

Trust Point Inc first reported a position in MDT in Q4 2023 and has held it in 11 quarters since. The position peaked at $1.06M in Q2 2025. 673 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Trust Point Inc held 5,711 shares of Medtronic worth $447K as of Q2 2026.
  • Trust Point Inc sold 2,438 Medtronic shares in Q2 2026, an estimated $197K.
  • Medtronic made up 0.04% of Trust Point Inc's portfolio in Q2 2026, its #247 holding.
  • Trust Point Inc first reported a position in Medtronic in Q4 2023 and has held it in 11 quarters since.
  • Trust Point Inc's Medtronic position peaked at $1.06M in Q2 2025.
  • 673 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Trust Point Inc's 13F filing for Q2 2026, filed 8 Jul 2026.